Wealthfront Advisers LLC lessened its stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 70.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 64,553 shares of the real estate investment trust’s stock after selling 151,932 shares during the quarter. Wealthfront Advisers LLC’s holdings in Healthpeak Properties were worth $1,236,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the stock. Vanderbilt University purchased a new stake in shares of Healthpeak Properties during the third quarter worth about $1,263,000. Northside Capital Management LLC acquired a new stake in Healthpeak Properties in the 3rd quarter worth about $6,123,000. Baird Financial Group Inc. increased its stake in Healthpeak Properties by 38.5% during the 2nd quarter. Baird Financial Group Inc. now owns 402,466 shares of the real estate investment trust’s stock worth $7,047,000 after buying an additional 111,807 shares in the last quarter. Argent Advisors Inc. acquired a new position in shares of Healthpeak Properties during the third quarter valued at approximately $1,536,000. Finally, Trust Co. of Toledo NA OH lifted its position in shares of Healthpeak Properties by 8,859.2% in the third quarter. Trust Co. of Toledo NA OH now owns 82,425 shares of the real estate investment trust’s stock valued at $1,578,000 after acquiring an additional 81,505 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Stock Performance
NYSE:DOC opened at $16.70 on Monday. The company’s 50-day moving average is $16.79 and its two-hundred day moving average is $17.55. Healthpeak Properties, Inc. has a 1-year low of $15.71 and a 1-year high of $21.28. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82. The firm has a market capitalization of $11.60 billion, a price-to-earnings ratio of 166.97, a PEG ratio of 8.96 and a beta of 1.12.
Healthpeak Properties Dividend Announcement
The business also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a yield of 7.3%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s payout ratio is 1,220.00%.
Analyst Ratings Changes
DOC has been the subject of several recent research reports. Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Argus lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Finally, Evercore decreased their target price on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Hold” and an average price target of $19.42.
Check Out Our Latest Report on Healthpeak Properties
Healthpeak Properties Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
